Notably, some of these conditions have also been found to involve increased fibulin-3 expression levels (CTS [104] and glioma [107]), so it is possible that this specific SNP in the enhancer region leads to pathological EFEMP1 overexpression. This evidence concerns the gene EFEMP1 and glioma.